Suppr超能文献

中国百日咳负担研究(百日咳中国研究):一项基于人群的前瞻性病例对照研究方案

Burden of whooping cough in China (PertussisChina): study protocol of a prospective, population-based case-control study.

作者信息

Yu Jianxing, He Hanqing, Zhang Yanyang, Gao Yuan, Chen Chuanwei, Xu Juan, Xu Li, Zhang Xiaoxiao, Zhou Qianqian, Zhu Yao, Tang Xuewen, Guo Yonghao, Chen Zhiping, Shao Zhujun

机构信息

National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, P.R.China.

Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Binjiang District, China.

出版信息

BMJ Open. 2022 Mar 10;12(3):e053316. doi: 10.1136/bmjopen-2021-053316.

Abstract

INTRODUCTION

Pertussis is one of the top 10 diseases of children under 10 years of age, and the few vaccine-preventable diseases who is on a rise in China in recent years; however, the true burden of pertussis, including age-stratified incidence and risk factors of severe sequelae, are under-recognised. We aim to estimate the health burden of laboratory-confirmed pertussis by age groups, considering the setting of illness onset (ie, in community, outpatient and inpatient), in a Chinese population (~2.23 million in total) at two sites.

METHODS AND ANALYSIS

This paper describes the study design of a 1-year, prospective, age-stratified and population-based case-control study, including site selection, study population, case registry, ascertainment and enrolment, control recruitment, follow-up of case, microbiological methods, data collection, quality control activities and statistical methods used to generate incidence estimates. During June 2021 through May 2022, registry of suspected pertussis cases (namely chronic/persistent cough) will be conducted in several participating hospitals (SHs) at the two sites, which are selected based on Healthcare Utilisation and Attitudes Surveys (HUAS) carried out before study initiation. A case-control study will be conducted in the SHs and we aim to enrol a total of 1000 suspected pertussis cases (ie, all hospital admissions and the first 1-3 outpatient visits each week each hospital) and 2000 frequency matched healthy controls in community. Our primary study outcome, the laboratory-confirmed infection, will be determined by a comprehensive laboratory methods and procedures (ie, culture, PCR and serological tests) in both cases and controls at enrolment and during 60-day's follow-up visits. Finally, data from HUAS (ie, population size), case registry (ie, the total number of suspected pertussis cases) and case-control study (ie, the prevalence or population attributable fraction of ) will be combined to calculate incidence and its 95% CI through bootstrap method. Epidemiological analyses will be conducted to determine the risk factors associated with severe sequelae of pertussis.

ETHICS AND DISSEMINATION

This study has been approved by Chinese Centre for Disease Control and Prevention's Institutional Review Board (no. ICDC-202110). Results will be disseminated via academic presentations and publication in peer-reviewed journals, and will provide valuable scientific data and some new insights into the incidence, aetiology and risk factors for severe sequelae of pertussis to academic societies and the public health authorities who is currently struggling and fighting against this burdensome disease worldwide.

摘要

简介

百日咳是10岁以下儿童的十大疾病之一,是近年来中国少数几种呈上升趋势的疫苗可预防疾病;然而,百日咳的真实负担,包括按年龄分层的发病率和严重后遗症的危险因素,尚未得到充分认识。我们旨在按年龄组估计实验室确诊百日咳的健康负担,考虑发病背景(即社区、门诊和住院),在中国两个地点的人群(总计约223万)中进行研究。

方法与分析

本文描述了一项为期1年的前瞻性、按年龄分层的基于人群的病例对照研究的研究设计,包括地点选择、研究人群、病例登记、确定和招募、对照招募、病例随访、微生物学方法、数据收集、质量控制活动以及用于生成发病率估计值的统计方法。在2021年6月至2022年5月期间,将在两个地点的几家参与医院(SHs)对疑似百日咳病例(即慢性/持续性咳嗽)进行登记,这些医院是根据研究开始前进行的医疗保健利用和态度调查(HUAS)选定的。将在这些医院进行病例对照研究,我们的目标是总共招募1000例疑似百日咳病例(即所有住院患者以及每家医院每周的前1 - 3次门诊就诊患者)和2000名在社区中频率匹配的健康对照。我们的主要研究结局,即实验室确诊感染,将通过在入组时以及60天随访期间对病例和对照采用综合实验室方法和程序(即培养、PCR和血清学检测)来确定。最后,将来自HUAS的数据(即人口规模)、病例登记数据(即疑似百日咳病例总数)和病例对照研究数据(即患病率或人群归因分数)相结合,通过自助法计算发病率及其95%置信区间。将进行流行病学分析以确定与百日咳严重后遗症相关的危险因素。

伦理与传播

本研究已获得中国疾病预防控制中心机构审查委员会的批准(编号:ICDC - 202110)。研究结果将通过学术报告和在同行评审期刊上发表进行传播,并将为学术团体和全球目前正在与这种负担沉重的疾病作斗争的公共卫生当局提供有关百日咳发病率、病因和严重后遗症危险因素的宝贵科学数据和一些新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfb6/8915282/bc22d01eefb4/bmjopen-2021-053316f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验